Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition (Q39913573)

15 September 2017

title

Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition (English)

1 reference

15 September 2017

Jayne Gilbert

5

0 references

Timothy Hill

Timothy A Hill

1

0 references

Jennette A Sakoff

Jennette A Sakoff

7

0 references

Christopher Gordon

Christopher P Gordon

3

0 references

Adam McCluskey

Adam McCluskey

8

0 references

author name string

Scott G Stewart

2

1 reference

15 September 2017

Stephen P Ackland

4

1 reference

15 September 2017

Benjamin Sauer

6

1 reference

15 September 2017

publication date

1 December 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

3

1 reference

15 September 2017

issue

12

1 reference

15 September 2017

page(s)

1878-1892

1 reference

Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

The microcystins and nodularins: cyclic polypeptide inhibitors of PP1 and PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

Fostriecin: chemistry and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

Synthesis of specific protein phosphatase inhibitors, tautomycin and tautomycetin toward structure-activity relationship study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

Regulators of serine/threonine protein phosphatases at the dawn of a clinical era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

Serine/threonine protein phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

Small molecule inhibitors of serine/threonine protein phosphatases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Protein phosphatase inhibition: structure based design. Towards new therapeutic agents

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Medical uses of mylabris in ancient China and recent studies

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

The effect of cantharidin on epithelial cells in tissue culture

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cells

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aalpha

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Effects of cantharidinimides on human carcinoma cells

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Protein phosphatase 2A: the Trojan Horse of cellular signaling

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Protein phosphatase 2A: who shall regulate the regulator?

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Protein phosphatase 2A: a panoply of enzymes.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Three novel cantharidin-related compounds from the Chinese blister beetle, Mylabris phalerata Pall

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

2-Carboxymethylendothal analogues as affinity probes for stabilized protein phosphatase 2A.

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Inhibition of the ser-thr phosphatases PP1 and PP2A by naturally occurring toxins

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

A new model of the tautomycin-PP1 complex that is not analogous to the corresponding okadaic acid structure

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Heterocyclic substituted cantharidin and norcantharidin analogues—synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity

1 reference

https://api.crossref.org/works/10.1002/CMDC.200800192

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800192

1 reference

release_gwgbo3qtafe5fco25yla6gxtf4

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gwgbo3qtafe5fco25yla6gxtf4

24 November 2022

mapped directly with Wikidata item

1 reference